A history of prostate cancer treatment

By S. Denmeade, J. Isaacs. Nature Reviews. Cancer, 2002

598 citations recorded by the source corpus.

Subfields: Cancer Research, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/1aabdc1f7e0592d704ac4d986566beb52c7c3802

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Hong Wu
2. J. Jiao
3. G. Thomas
4. P. Roy-burman
5. Douglas E. Linn
6. J. Melamed
7. Zhiyong Guo
8. H. Kung

Citations in the corpus

• A Novel Androgen Receptor Splice Variant Is Upregulated during Prostate Cancer Progression and Promotes Androgen-depletion-resistant Growth (2009, methodology): “PCR products from input (1), immunoprecipitation with anti-AR3 (2 ), anti-AR (3), or the control antibody (4 ) were resolved on agarose gels (left ).”
• Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. (2003, background): “The males offspring with PtenL/ ;C and survival (Denmeade and Isaacs, 2002).”